Global Eye Injection Market Growth 2026-2032
The global Eye Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Eye Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Eye Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Eye Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Eye Injection players cover Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Eye Injection Industry Forecast? looks at past sales and reviews total world Eye Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Eye Injection sales for 2026 through 2032. With Eye Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eye Injection industry.
This Insight Report provides a comprehensive analysis of the global Eye Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Eye Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Eye Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eye Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eye Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Eye Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Eye Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Eye Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Eye Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Eye Injection players cover Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Eye Injection Industry Forecast? looks at past sales and reviews total world Eye Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Eye Injection sales for 2026 through 2032. With Eye Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eye Injection industry.
This Insight Report provides a comprehensive analysis of the global Eye Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Eye Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Eye Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eye Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eye Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Eye Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Ranibizumab
- Bevacizumab
- Aflibercept
- Brolucizumab
- Faricimab
- Others
- Age-related Macular Degeneration (AMD)
- Diabetic Retinopathy
- Retinal Vein Occlusion (RVO)
- Retinopathy of Prematurity (ROP)
- Uveitis
- Neovascular Glaucoma
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Novartis
- Bayer
- Genentech
- Apellis Pharmaceuticals, Inc.
- Coherus BioSciences Inc.
- Iveric Bio
- Regeneron
- Roche
- Fagron
- Qilu Pharmaceutical Co.,Ltd.
- Chengdu Kanghong Pharmaceutical Group
- What is the 10-year outlook for the global Eye Injection market?
- What factors are driving Eye Injection market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Eye Injection market opportunities vary by end market size?
- How does Eye Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Eye Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Eye Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Eye Injection by Country/Region, 2021, 2025 & 2032
2.2 Eye Injection Segment by Type
2.2.1 Ranibizumab
2.2.2 Bevacizumab
2.2.3 Aflibercept
2.2.4 Brolucizumab
2.2.5 Faricimab
2.2.6 Others
2.2.7 Eye Injection Sales by Type
2.2.7.1 Global Eye Injection Sales Market Share by Type (2021-2026)
2.2.7.2 Global Eye Injection Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Eye Injection Sale Price by Type (2021-2026)
2.3 Eye Injection Segment by Application
2.3.1 Age-related Macular Degeneration (AMD)
2.3.2 Diabetic Retinopathy
2.3.3 Retinal Vein Occlusion (RVO)
2.3.4 Retinopathy of Prematurity (ROP)
2.3.5 Uveitis
2.3.6 Neovascular Glaucoma
2.3.7 Others
2.3.8 Eye Injection Sales by Application
2.3.8.1 Global Eye Injection Sale Market Share by Application (2021-2026)
2.3.8.2 Global Eye Injection Revenue and Market Share by Application (2021-2026)
2.3.8.3 Global Eye Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Eye Injection Breakdown Data by Company
3.1.1 Global Eye Injection Annual Sales by Company (2021-2026)
3.1.2 Global Eye Injection Sales Market Share by Company (2021-2026)
3.2 Global Eye Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Eye Injection Revenue by Company (2021-2026)
3.2.2 Global Eye Injection Revenue Market Share by Company (2021-2026)
3.3 Global Eye Injection Sale Price by Company
3.4 Key Manufacturers Eye Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Eye Injection Product Location Distribution
3.4.2 Players Eye Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EYE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Eye Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Eye Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Eye Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Eye Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Eye Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Eye Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Eye Injection Sales Growth
4.4 APAC Eye Injection Sales Growth
4.5 Europe Eye Injection Sales Growth
4.6 Middle East & Africa Eye Injection Sales Growth
5 AMERICAS
5.1 Americas Eye Injection Sales by Country
5.1.1 Americas Eye Injection Sales by Country (2021-2026)
5.1.2 Americas Eye Injection Revenue by Country (2021-2026)
5.2 Americas Eye Injection Sales by Type (2021-2026)
5.3 Americas Eye Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Eye Injection Sales by Region
6.1.1 APAC Eye Injection Sales by Region (2021-2026)
6.1.2 APAC Eye Injection Revenue by Region (2021-2026)
6.2 APAC Eye Injection Sales by Type (2021-2026)
6.3 APAC Eye Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Eye Injection by Country
7.1.1 Europe Eye Injection Sales by Country (2021-2026)
7.1.2 Europe Eye Injection Revenue by Country (2021-2026)
7.2 Europe Eye Injection Sales by Type (2021-2026)
7.3 Europe Eye Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Eye Injection by Country
8.1.1 Middle East & Africa Eye Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Eye Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Eye Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Eye Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Eye Injection
10.3 Manufacturing Process Analysis of Eye Injection
10.4 Industry Chain Structure of Eye Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Eye Injection Distributors
11.3 Eye Injection Customer
12 WORLD FORECAST REVIEW FOR EYE INJECTION BY GEOGRAPHIC REGION
12.1 Global Eye Injection Market Size Forecast by Region
12.1.1 Global Eye Injection Forecast by Region (2027-2032)
12.1.2 Global Eye Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Eye Injection Forecast by Type (2027-2032)
12.7 Global Eye Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Eye Injection Product Portfolios and Specifications
13.1.3 Sanofi Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Eye Injection Product Portfolios and Specifications
13.2.3 Novartis Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Eye Injection Product Portfolios and Specifications
13.3.3 Bayer Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Genentech
13.4.1 Genentech Company Information
13.4.2 Genentech Eye Injection Product Portfolios and Specifications
13.4.3 Genentech Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Genentech Main Business Overview
13.4.5 Genentech Latest Developments
13.5 Apellis Pharmaceuticals, Inc.
13.5.1 Apellis Pharmaceuticals, Inc. Company Information
13.5.2 Apellis Pharmaceuticals, Inc. Eye Injection Product Portfolios and Specifications
13.5.3 Apellis Pharmaceuticals, Inc. Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Apellis Pharmaceuticals, Inc. Main Business Overview
13.5.5 Apellis Pharmaceuticals, Inc. Latest Developments
13.6 Coherus BioSciences Inc.
13.6.1 Coherus BioSciences Inc. Company Information
13.6.2 Coherus BioSciences Inc. Eye Injection Product Portfolios and Specifications
13.6.3 Coherus BioSciences Inc. Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Coherus BioSciences Inc. Main Business Overview
13.6.5 Coherus BioSciences Inc. Latest Developments
13.7 Iveric Bio
13.7.1 Iveric Bio
Company Information
13.7.2 Iveric Bio
Eye Injection Product Portfolios and Specifications
13.7.3 Iveric Bio
Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Iveric Bio
Main Business Overview
13.7.5 Iveric Bio
Latest Developments
13.8 Regeneron
13.8.1 Regeneron Company Information
13.8.2 Regeneron Eye Injection Product Portfolios and Specifications
13.8.3 Regeneron Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Regeneron Main Business Overview
13.8.5 Regeneron Latest Developments
13.9 Roche
13.9.1 Roche Company Information
13.9.2 Roche Eye Injection Product Portfolios and Specifications
13.9.3 Roche Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Roche Main Business Overview
13.9.5 Roche Latest Developments
13.10 Fagron
13.10.1 Fagron Company Information
13.10.2 Fagron Eye Injection Product Portfolios and Specifications
13.10.3 Fagron Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Fagron Main Business Overview
13.10.5 Fagron Latest Developments
13.11 Qilu Pharmaceutical Co.,Ltd.
13.11.1 Qilu Pharmaceutical Co.,Ltd. Company Information
13.11.2 Qilu Pharmaceutical Co.,Ltd. Eye Injection Product Portfolios and Specifications
13.11.3 Qilu Pharmaceutical Co.,Ltd. Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Qilu Pharmaceutical Co.,Ltd. Main Business Overview
13.11.5 Qilu Pharmaceutical Co.,Ltd. Latest Developments
13.12 Chengdu Kanghong Pharmaceutical Group
13.12.1 Chengdu Kanghong Pharmaceutical Group Company Information
13.12.2 Chengdu Kanghong Pharmaceutical Group Eye Injection Product Portfolios and Specifications
13.12.3 Chengdu Kanghong Pharmaceutical Group Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Chengdu Kanghong Pharmaceutical Group Main Business Overview
13.12.5 Chengdu Kanghong Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Eye Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Eye Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Eye Injection by Country/Region, 2021, 2025 & 2032
2.2 Eye Injection Segment by Type
2.2.1 Ranibizumab
2.2.2 Bevacizumab
2.2.3 Aflibercept
2.2.4 Brolucizumab
2.2.5 Faricimab
2.2.6 Others
2.2.7 Eye Injection Sales by Type
2.2.7.1 Global Eye Injection Sales Market Share by Type (2021-2026)
2.2.7.2 Global Eye Injection Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Eye Injection Sale Price by Type (2021-2026)
2.3 Eye Injection Segment by Application
2.3.1 Age-related Macular Degeneration (AMD)
2.3.2 Diabetic Retinopathy
2.3.3 Retinal Vein Occlusion (RVO)
2.3.4 Retinopathy of Prematurity (ROP)
2.3.5 Uveitis
2.3.6 Neovascular Glaucoma
2.3.7 Others
2.3.8 Eye Injection Sales by Application
2.3.8.1 Global Eye Injection Sale Market Share by Application (2021-2026)
2.3.8.2 Global Eye Injection Revenue and Market Share by Application (2021-2026)
2.3.8.3 Global Eye Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Eye Injection Breakdown Data by Company
3.1.1 Global Eye Injection Annual Sales by Company (2021-2026)
3.1.2 Global Eye Injection Sales Market Share by Company (2021-2026)
3.2 Global Eye Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Eye Injection Revenue by Company (2021-2026)
3.2.2 Global Eye Injection Revenue Market Share by Company (2021-2026)
3.3 Global Eye Injection Sale Price by Company
3.4 Key Manufacturers Eye Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Eye Injection Product Location Distribution
3.4.2 Players Eye Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EYE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Eye Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Eye Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Eye Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Eye Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Eye Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Eye Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Eye Injection Sales Growth
4.4 APAC Eye Injection Sales Growth
4.5 Europe Eye Injection Sales Growth
4.6 Middle East & Africa Eye Injection Sales Growth
5 AMERICAS
5.1 Americas Eye Injection Sales by Country
5.1.1 Americas Eye Injection Sales by Country (2021-2026)
5.1.2 Americas Eye Injection Revenue by Country (2021-2026)
5.2 Americas Eye Injection Sales by Type (2021-2026)
5.3 Americas Eye Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Eye Injection Sales by Region
6.1.1 APAC Eye Injection Sales by Region (2021-2026)
6.1.2 APAC Eye Injection Revenue by Region (2021-2026)
6.2 APAC Eye Injection Sales by Type (2021-2026)
6.3 APAC Eye Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Eye Injection by Country
7.1.1 Europe Eye Injection Sales by Country (2021-2026)
7.1.2 Europe Eye Injection Revenue by Country (2021-2026)
7.2 Europe Eye Injection Sales by Type (2021-2026)
7.3 Europe Eye Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Eye Injection by Country
8.1.1 Middle East & Africa Eye Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Eye Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Eye Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Eye Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Eye Injection
10.3 Manufacturing Process Analysis of Eye Injection
10.4 Industry Chain Structure of Eye Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Eye Injection Distributors
11.3 Eye Injection Customer
12 WORLD FORECAST REVIEW FOR EYE INJECTION BY GEOGRAPHIC REGION
12.1 Global Eye Injection Market Size Forecast by Region
12.1.1 Global Eye Injection Forecast by Region (2027-2032)
12.1.2 Global Eye Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Eye Injection Forecast by Type (2027-2032)
12.7 Global Eye Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Eye Injection Product Portfolios and Specifications
13.1.3 Sanofi Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Eye Injection Product Portfolios and Specifications
13.2.3 Novartis Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Eye Injection Product Portfolios and Specifications
13.3.3 Bayer Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Genentech
13.4.1 Genentech Company Information
13.4.2 Genentech Eye Injection Product Portfolios and Specifications
13.4.3 Genentech Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Genentech Main Business Overview
13.4.5 Genentech Latest Developments
13.5 Apellis Pharmaceuticals, Inc.
13.5.1 Apellis Pharmaceuticals, Inc. Company Information
13.5.2 Apellis Pharmaceuticals, Inc. Eye Injection Product Portfolios and Specifications
13.5.3 Apellis Pharmaceuticals, Inc. Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Apellis Pharmaceuticals, Inc. Main Business Overview
13.5.5 Apellis Pharmaceuticals, Inc. Latest Developments
13.6 Coherus BioSciences Inc.
13.6.1 Coherus BioSciences Inc. Company Information
13.6.2 Coherus BioSciences Inc. Eye Injection Product Portfolios and Specifications
13.6.3 Coherus BioSciences Inc. Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Coherus BioSciences Inc. Main Business Overview
13.6.5 Coherus BioSciences Inc. Latest Developments
13.7 Iveric Bio
13.7.1 Iveric Bio
Company Information
13.7.2 Iveric Bio
Eye Injection Product Portfolios and Specifications
13.7.3 Iveric Bio
Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Iveric Bio
Main Business Overview
13.7.5 Iveric Bio
Latest Developments
13.8 Regeneron
13.8.1 Regeneron Company Information
13.8.2 Regeneron Eye Injection Product Portfolios and Specifications
13.8.3 Regeneron Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Regeneron Main Business Overview
13.8.5 Regeneron Latest Developments
13.9 Roche
13.9.1 Roche Company Information
13.9.2 Roche Eye Injection Product Portfolios and Specifications
13.9.3 Roche Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Roche Main Business Overview
13.9.5 Roche Latest Developments
13.10 Fagron
13.10.1 Fagron Company Information
13.10.2 Fagron Eye Injection Product Portfolios and Specifications
13.10.3 Fagron Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Fagron Main Business Overview
13.10.5 Fagron Latest Developments
13.11 Qilu Pharmaceutical Co.,Ltd.
13.11.1 Qilu Pharmaceutical Co.,Ltd. Company Information
13.11.2 Qilu Pharmaceutical Co.,Ltd. Eye Injection Product Portfolios and Specifications
13.11.3 Qilu Pharmaceutical Co.,Ltd. Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Qilu Pharmaceutical Co.,Ltd. Main Business Overview
13.11.5 Qilu Pharmaceutical Co.,Ltd. Latest Developments
13.12 Chengdu Kanghong Pharmaceutical Group
13.12.1 Chengdu Kanghong Pharmaceutical Group Company Information
13.12.2 Chengdu Kanghong Pharmaceutical Group Eye Injection Product Portfolios and Specifications
13.12.3 Chengdu Kanghong Pharmaceutical Group Eye Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Chengdu Kanghong Pharmaceutical Group Main Business Overview
13.12.5 Chengdu Kanghong Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Eye Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Eye Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Ranibizumab
Table 4. Major Players of Bevacizumab
Table 5. Major Players of Aflibercept
Table 6. Major Players of Brolucizumab
Table 7. Major Players of Faricimab
Table 8. Major Players of Others
Table 9. Global Eye Injection Sales by Type (2021-2026) & (K Units)
Table 10. Global Eye Injection Sales Market Share by Type (2021-2026)
Table 11. Global Eye Injection Revenue by Type (2021-2026) & ($ million)
Table 12. Global Eye Injection Revenue Market Share by Type (2021-2026)
Table 13. Global Eye Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Global Eye Injection Sale by Application (2021-2026) & (K Units)
Table 15. Global Eye Injection Sale Market Share by Application (2021-2026)
Table 16. Global Eye Injection Revenue by Application (2021-2026) & ($ million)
Table 17. Global Eye Injection Revenue Market Share by Application (2021-2026)
Table 18. Global Eye Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 19. Global Eye Injection Sales by Company (2021-2026) & (K Units)
Table 20. Global Eye Injection Sales Market Share by Company (2021-2026)
Table 21. Global Eye Injection Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Eye Injection Revenue Market Share by Company (2021-2026)
Table 23. Global Eye Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 24. Key Manufacturers Eye Injection Producing Area Distribution and Sales Area
Table 25. Players Eye Injection Products Offered
Table 26. Eye Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Eye Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 30. Global Eye Injection Sales Market Share Geographic Region (2021-2026)
Table 31. Global Eye Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Eye Injection Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Eye Injection Sales by Country/Region (2021-2026) & (K Units)
Table 34. Global Eye Injection Sales Market Share by Country/Region (2021-2026)
Table 35. Global Eye Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Eye Injection Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Eye Injection Sales by Country (2021-2026) & (K Units)
Table 38. Americas Eye Injection Sales Market Share by Country (2021-2026)
Table 39. Americas Eye Injection Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Eye Injection Sales by Type (2021-2026) & (K Units)
Table 41. Americas Eye Injection Sales by Application (2021-2026) & (K Units)
Table 42. APAC Eye Injection Sales by Region (2021-2026) & (K Units)
Table 43. APAC Eye Injection Sales Market Share by Region (2021-2026)
Table 44. APAC Eye Injection Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Eye Injection Sales by Type (2021-2026) & (K Units)
Table 46. APAC Eye Injection Sales by Application (2021-2026) & (K Units)
Table 47. Europe Eye Injection Sales by Country (2021-2026) & (K Units)
Table 48. Europe Eye Injection Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Eye Injection Sales by Type (2021-2026) & (K Units)
Table 50. Europe Eye Injection Sales by Application (2021-2026) & (K Units)
Table 51. Middle East & Africa Eye Injection Sales by Country (2021-2026) & (K Units)
Table 52. Middle East & Africa Eye Injection Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Eye Injection Sales by Type (2021-2026) & (K Units)
Table 54. Middle East & Africa Eye Injection Sales by Application (2021-2026) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Eye Injection
Table 56. Key Market Challenges & Risks of Eye Injection
Table 57. Key Industry Trends of Eye Injection
Table 58. Eye Injection Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Eye Injection Distributors List
Table 61. Eye Injection Customer List
Table 62. Global Eye Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. Global Eye Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Eye Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Americas Eye Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Eye Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 67. APAC Eye Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Eye Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Europe Eye Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Eye Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Middle East & Africa Eye Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Eye Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 73. Global Eye Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Eye Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 75. Global Eye Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. Sanofi Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 77. Sanofi Eye Injection Product Portfolios and Specifications
Table 78. Sanofi Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. Sanofi Main Business
Table 80. Sanofi Latest Developments
Table 81. Novartis Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 82. Novartis Eye Injection Product Portfolios and Specifications
Table 83. Novartis Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Novartis Main Business
Table 85. Novartis Latest Developments
Table 86. Bayer Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 87. Bayer Eye Injection Product Portfolios and Specifications
Table 88. Bayer Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Bayer Main Business
Table 90. Bayer Latest Developments
Table 91. Genentech Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 92. Genentech Eye Injection Product Portfolios and Specifications
Table 93. Genentech Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Genentech Main Business
Table 95. Genentech Latest Developments
Table 96. Apellis Pharmaceuticals, Inc. Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 97. Apellis Pharmaceuticals, Inc. Eye Injection Product Portfolios and Specifications
Table 98. Apellis Pharmaceuticals, Inc. Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Apellis Pharmaceuticals, Inc. Main Business
Table 100. Apellis Pharmaceuticals, Inc. Latest Developments
Table 101. Coherus BioSciences Inc. Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 102. Coherus BioSciences Inc. Eye Injection Product Portfolios and Specifications
Table 103. Coherus BioSciences Inc. Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Coherus BioSciences Inc. Main Business
Table 105. Coherus BioSciences Inc. Latest Developments
Table 106. Iveric Bio
Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 107. Iveric Bio
Eye Injection Product Portfolios and Specifications
Table 108. Iveric Bio
Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Iveric Bio
Main Business
Table 110. Iveric Bio
Latest Developments
Table 111. Regeneron Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 112. Regeneron Eye Injection Product Portfolios and Specifications
Table 113. Regeneron Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Regeneron Main Business
Table 115. Regeneron Latest Developments
Table 116. Roche Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 117. Roche Eye Injection Product Portfolios and Specifications
Table 118. Roche Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Roche Main Business
Table 120. Roche Latest Developments
Table 121. Fagron Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 122. Fagron Eye Injection Product Portfolios and Specifications
Table 123. Fagron Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Fagron Main Business
Table 125. Fagron Latest Developments
Table 126. Qilu Pharmaceutical Co.,Ltd. Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 127. Qilu Pharmaceutical Co.,Ltd. Eye Injection Product Portfolios and Specifications
Table 128. Qilu Pharmaceutical Co.,Ltd. Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Qilu Pharmaceutical Co.,Ltd. Main Business
Table 130. Qilu Pharmaceutical Co.,Ltd. Latest Developments
Table 131. Chengdu Kanghong Pharmaceutical Group Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 132. Chengdu Kanghong Pharmaceutical Group Eye Injection Product Portfolios and Specifications
Table 133. Chengdu Kanghong Pharmaceutical Group Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Chengdu Kanghong Pharmaceutical Group Main Business
Table 135. Chengdu Kanghong Pharmaceutical Group Latest Developments
Table 1. Eye Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Eye Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Ranibizumab
Table 4. Major Players of Bevacizumab
Table 5. Major Players of Aflibercept
Table 6. Major Players of Brolucizumab
Table 7. Major Players of Faricimab
Table 8. Major Players of Others
Table 9. Global Eye Injection Sales by Type (2021-2026) & (K Units)
Table 10. Global Eye Injection Sales Market Share by Type (2021-2026)
Table 11. Global Eye Injection Revenue by Type (2021-2026) & ($ million)
Table 12. Global Eye Injection Revenue Market Share by Type (2021-2026)
Table 13. Global Eye Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Global Eye Injection Sale by Application (2021-2026) & (K Units)
Table 15. Global Eye Injection Sale Market Share by Application (2021-2026)
Table 16. Global Eye Injection Revenue by Application (2021-2026) & ($ million)
Table 17. Global Eye Injection Revenue Market Share by Application (2021-2026)
Table 18. Global Eye Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 19. Global Eye Injection Sales by Company (2021-2026) & (K Units)
Table 20. Global Eye Injection Sales Market Share by Company (2021-2026)
Table 21. Global Eye Injection Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Eye Injection Revenue Market Share by Company (2021-2026)
Table 23. Global Eye Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 24. Key Manufacturers Eye Injection Producing Area Distribution and Sales Area
Table 25. Players Eye Injection Products Offered
Table 26. Eye Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Eye Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 30. Global Eye Injection Sales Market Share Geographic Region (2021-2026)
Table 31. Global Eye Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Eye Injection Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Eye Injection Sales by Country/Region (2021-2026) & (K Units)
Table 34. Global Eye Injection Sales Market Share by Country/Region (2021-2026)
Table 35. Global Eye Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Eye Injection Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Eye Injection Sales by Country (2021-2026) & (K Units)
Table 38. Americas Eye Injection Sales Market Share by Country (2021-2026)
Table 39. Americas Eye Injection Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Eye Injection Sales by Type (2021-2026) & (K Units)
Table 41. Americas Eye Injection Sales by Application (2021-2026) & (K Units)
Table 42. APAC Eye Injection Sales by Region (2021-2026) & (K Units)
Table 43. APAC Eye Injection Sales Market Share by Region (2021-2026)
Table 44. APAC Eye Injection Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Eye Injection Sales by Type (2021-2026) & (K Units)
Table 46. APAC Eye Injection Sales by Application (2021-2026) & (K Units)
Table 47. Europe Eye Injection Sales by Country (2021-2026) & (K Units)
Table 48. Europe Eye Injection Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Eye Injection Sales by Type (2021-2026) & (K Units)
Table 50. Europe Eye Injection Sales by Application (2021-2026) & (K Units)
Table 51. Middle East & Africa Eye Injection Sales by Country (2021-2026) & (K Units)
Table 52. Middle East & Africa Eye Injection Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Eye Injection Sales by Type (2021-2026) & (K Units)
Table 54. Middle East & Africa Eye Injection Sales by Application (2021-2026) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Eye Injection
Table 56. Key Market Challenges & Risks of Eye Injection
Table 57. Key Industry Trends of Eye Injection
Table 58. Eye Injection Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Eye Injection Distributors List
Table 61. Eye Injection Customer List
Table 62. Global Eye Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. Global Eye Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Eye Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Americas Eye Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Eye Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 67. APAC Eye Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Eye Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Europe Eye Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Eye Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Middle East & Africa Eye Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Eye Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 73. Global Eye Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Eye Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 75. Global Eye Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. Sanofi Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 77. Sanofi Eye Injection Product Portfolios and Specifications
Table 78. Sanofi Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. Sanofi Main Business
Table 80. Sanofi Latest Developments
Table 81. Novartis Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 82. Novartis Eye Injection Product Portfolios and Specifications
Table 83. Novartis Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Novartis Main Business
Table 85. Novartis Latest Developments
Table 86. Bayer Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 87. Bayer Eye Injection Product Portfolios and Specifications
Table 88. Bayer Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Bayer Main Business
Table 90. Bayer Latest Developments
Table 91. Genentech Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 92. Genentech Eye Injection Product Portfolios and Specifications
Table 93. Genentech Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Genentech Main Business
Table 95. Genentech Latest Developments
Table 96. Apellis Pharmaceuticals, Inc. Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 97. Apellis Pharmaceuticals, Inc. Eye Injection Product Portfolios and Specifications
Table 98. Apellis Pharmaceuticals, Inc. Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Apellis Pharmaceuticals, Inc. Main Business
Table 100. Apellis Pharmaceuticals, Inc. Latest Developments
Table 101. Coherus BioSciences Inc. Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 102. Coherus BioSciences Inc. Eye Injection Product Portfolios and Specifications
Table 103. Coherus BioSciences Inc. Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Coherus BioSciences Inc. Main Business
Table 105. Coherus BioSciences Inc. Latest Developments
Table 106. Iveric Bio
Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 107. Iveric Bio
Eye Injection Product Portfolios and Specifications
Table 108. Iveric Bio
Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Iveric Bio
Main Business
Table 110. Iveric Bio
Latest Developments
Table 111. Regeneron Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 112. Regeneron Eye Injection Product Portfolios and Specifications
Table 113. Regeneron Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Regeneron Main Business
Table 115. Regeneron Latest Developments
Table 116. Roche Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 117. Roche Eye Injection Product Portfolios and Specifications
Table 118. Roche Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Roche Main Business
Table 120. Roche Latest Developments
Table 121. Fagron Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 122. Fagron Eye Injection Product Portfolios and Specifications
Table 123. Fagron Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Fagron Main Business
Table 125. Fagron Latest Developments
Table 126. Qilu Pharmaceutical Co.,Ltd. Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 127. Qilu Pharmaceutical Co.,Ltd. Eye Injection Product Portfolios and Specifications
Table 128. Qilu Pharmaceutical Co.,Ltd. Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Qilu Pharmaceutical Co.,Ltd. Main Business
Table 130. Qilu Pharmaceutical Co.,Ltd. Latest Developments
Table 131. Chengdu Kanghong Pharmaceutical Group Basic Information, Eye Injection Manufacturing Base, Sales Area and Its Competitors
Table 132. Chengdu Kanghong Pharmaceutical Group Eye Injection Product Portfolios and Specifications
Table 133. Chengdu Kanghong Pharmaceutical Group Eye Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Chengdu Kanghong Pharmaceutical Group Main Business
Table 135. Chengdu Kanghong Pharmaceutical Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of Eye Injection
Figure 2. Eye Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Eye Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Eye Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Eye Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Eye Injection Sales Market Share by Country/Region (2025)
Figure 10. Eye Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Ranibizumab
Figure 12. Product Picture of Bevacizumab
Figure 13. Product Picture of Aflibercept
Figure 14. Product Picture of Brolucizumab
Figure 15. Product Picture of Faricimab
Figure 16. Product Picture of Others
Figure 17. Global Eye Injection Sales Market Share by Type in 2026
Figure 18. Global Eye Injection Revenue Market Share by Type (2021-2026)
Figure 19. Eye Injection Consumed in Age-related Macular Degeneration (AMD)
Figure 20. Global Eye Injection Market: Age-related Macular Degeneration (AMD) (2021-2026) & (K Units)
Figure 21. Eye Injection Consumed in Diabetic Retinopathy
Figure 22. Global Eye Injection Market: Diabetic Retinopathy (2021-2026) & (K Units)
Figure 23. Eye Injection Consumed in Retinal Vein Occlusion (RVO)
Figure 24. Global Eye Injection Market: Retinal Vein Occlusion (RVO) (2021-2026) & (K Units)
Figure 25. Eye Injection Consumed in Retinopathy of Prematurity (ROP)
Figure 26. Global Eye Injection Market: Retinopathy of Prematurity (ROP) (2021-2026) & (K Units)
Figure 27. Eye Injection Consumed in Uveitis
Figure 28. Global Eye Injection Market: Uveitis (2021-2026) & (K Units)
Figure 29. Eye Injection Consumed in Neovascular Glaucoma
Figure 30. Global Eye Injection Market: Neovascular Glaucoma (2021-2026) & (K Units)
Figure 31. Eye Injection Consumed in Others
Figure 32. Global Eye Injection Market: Others (2021-2026) & (K Units)
Figure 33. Global Eye Injection Sale Market Share by Application (2025)
Figure 34. Global Eye Injection Revenue Market Share by Application in 2026
Figure 35. Eye Injection Sales by Company in 2026 (K Units)
Figure 36. Global Eye Injection Sales Market Share by Company in 2026
Figure 37. Eye Injection Revenue by Company in 2026 ($ millions)
Figure 38. Global Eye Injection Revenue Market Share by Company in 2026
Figure 39. Global Eye Injection Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Eye Injection Revenue Market Share by Geographic Region in 2026
Figure 41. Americas Eye Injection Sales 2021-2026 (K Units)
Figure 42. Americas Eye Injection Revenue 2021-2026 ($ millions)
Figure 43. APAC Eye Injection Sales 2021-2026 (K Units)
Figure 44. APAC Eye Injection Revenue 2021-2026 ($ millions)
Figure 45. Europe Eye Injection Sales 2021-2026 (K Units)
Figure 46. Europe Eye Injection Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Eye Injection Sales 2021-2026 (K Units)
Figure 48. Middle East & Africa Eye Injection Revenue 2021-2026 ($ millions)
Figure 49. Americas Eye Injection Sales Market Share by Country in 2026
Figure 50. Americas Eye Injection Revenue Market Share by Country (2021-2026)
Figure 51. Americas Eye Injection Sales Market Share by Type (2021-2026)
Figure 52. Americas Eye Injection Sales Market Share by Application (2021-2026)
Figure 53. United States Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Eye Injection Sales Market Share by Region in 2026
Figure 58. APAC Eye Injection Revenue Market Share by Region (2021-2026)
Figure 59. APAC Eye Injection Sales Market Share by Type (2021-2026)
Figure 60. APAC Eye Injection Sales Market Share by Application (2021-2026)
Figure 61. China Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. India Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Eye Injection Sales Market Share by Country in 2026
Figure 69. Europe Eye Injection Revenue Market Share by Country (2021-2026)
Figure 70. Europe Eye Injection Sales Market Share by Type (2021-2026)
Figure 71. Europe Eye Injection Sales Market Share by Application (2021-2026)
Figure 72. Germany Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. France Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Eye Injection Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Eye Injection Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Eye Injection Sales Market Share by Application (2021-2026)
Figure 80. Egypt Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Eye Injection in 2026
Figure 86. Manufacturing Process Analysis of Eye Injection
Figure 87. Industry Chain Structure of Eye Injection
Figure 88. Channels of Distribution
Figure 89. Global Eye Injection Sales Market Forecast by Region (2027-2032)
Figure 90. Global Eye Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Eye Injection Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Eye Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Eye Injection Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Eye Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Eye Injection
Figure 2. Eye Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Eye Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Eye Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Eye Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Eye Injection Sales Market Share by Country/Region (2025)
Figure 10. Eye Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Ranibizumab
Figure 12. Product Picture of Bevacizumab
Figure 13. Product Picture of Aflibercept
Figure 14. Product Picture of Brolucizumab
Figure 15. Product Picture of Faricimab
Figure 16. Product Picture of Others
Figure 17. Global Eye Injection Sales Market Share by Type in 2026
Figure 18. Global Eye Injection Revenue Market Share by Type (2021-2026)
Figure 19. Eye Injection Consumed in Age-related Macular Degeneration (AMD)
Figure 20. Global Eye Injection Market: Age-related Macular Degeneration (AMD) (2021-2026) & (K Units)
Figure 21. Eye Injection Consumed in Diabetic Retinopathy
Figure 22. Global Eye Injection Market: Diabetic Retinopathy (2021-2026) & (K Units)
Figure 23. Eye Injection Consumed in Retinal Vein Occlusion (RVO)
Figure 24. Global Eye Injection Market: Retinal Vein Occlusion (RVO) (2021-2026) & (K Units)
Figure 25. Eye Injection Consumed in Retinopathy of Prematurity (ROP)
Figure 26. Global Eye Injection Market: Retinopathy of Prematurity (ROP) (2021-2026) & (K Units)
Figure 27. Eye Injection Consumed in Uveitis
Figure 28. Global Eye Injection Market: Uveitis (2021-2026) & (K Units)
Figure 29. Eye Injection Consumed in Neovascular Glaucoma
Figure 30. Global Eye Injection Market: Neovascular Glaucoma (2021-2026) & (K Units)
Figure 31. Eye Injection Consumed in Others
Figure 32. Global Eye Injection Market: Others (2021-2026) & (K Units)
Figure 33. Global Eye Injection Sale Market Share by Application (2025)
Figure 34. Global Eye Injection Revenue Market Share by Application in 2026
Figure 35. Eye Injection Sales by Company in 2026 (K Units)
Figure 36. Global Eye Injection Sales Market Share by Company in 2026
Figure 37. Eye Injection Revenue by Company in 2026 ($ millions)
Figure 38. Global Eye Injection Revenue Market Share by Company in 2026
Figure 39. Global Eye Injection Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Eye Injection Revenue Market Share by Geographic Region in 2026
Figure 41. Americas Eye Injection Sales 2021-2026 (K Units)
Figure 42. Americas Eye Injection Revenue 2021-2026 ($ millions)
Figure 43. APAC Eye Injection Sales 2021-2026 (K Units)
Figure 44. APAC Eye Injection Revenue 2021-2026 ($ millions)
Figure 45. Europe Eye Injection Sales 2021-2026 (K Units)
Figure 46. Europe Eye Injection Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Eye Injection Sales 2021-2026 (K Units)
Figure 48. Middle East & Africa Eye Injection Revenue 2021-2026 ($ millions)
Figure 49. Americas Eye Injection Sales Market Share by Country in 2026
Figure 50. Americas Eye Injection Revenue Market Share by Country (2021-2026)
Figure 51. Americas Eye Injection Sales Market Share by Type (2021-2026)
Figure 52. Americas Eye Injection Sales Market Share by Application (2021-2026)
Figure 53. United States Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Eye Injection Sales Market Share by Region in 2026
Figure 58. APAC Eye Injection Revenue Market Share by Region (2021-2026)
Figure 59. APAC Eye Injection Sales Market Share by Type (2021-2026)
Figure 60. APAC Eye Injection Sales Market Share by Application (2021-2026)
Figure 61. China Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. India Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Eye Injection Sales Market Share by Country in 2026
Figure 69. Europe Eye Injection Revenue Market Share by Country (2021-2026)
Figure 70. Europe Eye Injection Sales Market Share by Type (2021-2026)
Figure 71. Europe Eye Injection Sales Market Share by Application (2021-2026)
Figure 72. Germany Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. France Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Eye Injection Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Eye Injection Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Eye Injection Sales Market Share by Application (2021-2026)
Figure 80. Egypt Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Eye Injection Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Eye Injection in 2026
Figure 86. Manufacturing Process Analysis of Eye Injection
Figure 87. Industry Chain Structure of Eye Injection
Figure 88. Channels of Distribution
Figure 89. Global Eye Injection Sales Market Forecast by Region (2027-2032)
Figure 90. Global Eye Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Eye Injection Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Eye Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Eye Injection Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Eye Injection Revenue Market Share Forecast by Application (2027-2032)
